MedTrace Logo

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances

NCT05876533 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 216

Last updated 2024-12-31

No results posted yet for this study

Summary

To determine the usability and technical aspects of Cordio HearO™

Conditions

Interventions

DEVICE

Cordio HearO

Cordio HearO is a software medical device that remotely monitors Congestive Heart Failure (CHF) patients by detecting changes in the patients' recorded voice relative to a baseline. The system is comprised of a mobile application (or "app") that is deployed on a mobile platform, and a web-based portal that enables caregivers to manage their patients

Sponsors & Collaborators

  • Cordio Medical

    lead INDUSTRY

Principal Investigators

  • Ronit Haviv, PhD · Cordio Medical

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-18
Primary Completion
2025-01-31
Completion
2025-03-15
FDA Device
Yes

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05876533 on ClinicalTrials.gov